Literature DB >> 26240134

Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer.

Davinia S Seah1, Sarah Scott1, Hao Guo1, Julie Najita1, Ruth Lederman1, Elizabeth Frank1, Jessica Sohl1, Zsofia Stadler1, Stuart Silverman1, Jeffrey Peppercorn1, Eric Winer1, Steve Come1, Nancy U Lin2.   

Abstract

BACKGROUND: Tissue from research biopsies provides access to insights into tumor biology. We aimed to determine medical oncologists' (MOs') attitudes toward research biopsies in patients with metastatic breast cancer (MBC).
MATERIALS AND METHODS: A total of 309 breast MOs from National Cancer Institute (NCI)-designated cancer centers were invited to complete a self-administered survey about their attitudes toward approaching patients for research purpose-only biopsies (RPOBs), performed as a standalone procedure, or additional biopsies, performed with a clinically indicated biopsy. The MOs were asked to predict what proportion of their MBC patients would consider undergoing research biopsies.
RESULTS: Of the 309 MOs, 221 (72%) responded. Of these 221 MOs, 30 were ineligible, leaving 191 eligible responders. Nearly all the MOs reported they were comfortable approaching patients regarding research biopsies of blood or skin. One fifth of MOs were uncomfortable approaching patients for RPOBs of the breast. One half of MOs were uncomfortable approaching patients for RPOBs of the liver. A significant variation was found in the perceptions by MOs of their patients' willingness to undergo research biopsies. The factors associated with increased comfort in approaching patients for research biopsies included fewer years in practice, caring for patients who had undergone recent research biopsies, and the predicted willingness of patients to consent to biopsies. The risk of a biopsy and biopsy-related pain were the most common reasons for reluctance to refer patients for research biopsies.
CONCLUSION: Significant variation exists, even at NCI centers, in the comfort level of MOs in approaching MBC patients for research biopsies. MOs' attitudes toward research biopsies might be a modifiable factor in increasing tissue collection for research. IMPLICATIONS FOR PRACTICE: Tissue-based research is critical in advancing our understanding of cancer biology, and obtaining tissue from a research biopsy provides an essential resource. This study demonstrates the variability of oncologists' attitudes toward research biopsies and elicits factors associated with increased comfort levels with approaching patients for research biopsies. Biopsy risk and biopsy-related pain were commonly cited reasons not to refer patients for research biopsies. If the risk of a research biopsy is deemed sufficiently low enough to be acceptable, oncologists' attitudes might be a potential target for education and change, which may assist in increasing the availability of tissue for cancer research. ©AlphaMed Press.

Entities:  

Keywords:  Attitudes; Metastatic breast cancer; Physicians; Research biopsies

Mesh:

Year:  2015        PMID: 26240134      PMCID: PMC4571800          DOI: 10.1634/theoncologist.2015-0112

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  18 in total

Review 1.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies.

Authors:  Sander Greenland
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

3.  Easy SAS calculations for risk or prevalence ratios and differences.

Authors:  Donna Spiegelman; Ellen Hertzmark
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

4.  Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.

Authors:  Hazem El-Osta; David Hong; Jennifer Wheler; Siqing Fu; Aung Naing; Gerald Falchook; Marshall Hicks; Sijin Wen; Apostolia M Tsimberidou; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-08-22

5.  Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.

Authors:  Mark Agulnik; Amit M Oza; Gregory R Pond; Lillian L Siu
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

6.  Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety.

Authors:  C A Gomez-Roca; L Lacroix; C Massard; T De Baere; F Deschamps; R Pramod; R Bahleda; E Deutsch; C Bourgier; E Angevin; V Lazar; V Ribrag; S Koscielny; L Chami; N Lassau; C Dromain; C Robert; E Routier; J P Armand; J-C Soria
Journal:  Ann Oncol       Date:  2011-09-14       Impact factor: 32.976

7.  Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.

Authors:  Jeffrey Peppercorn; Iuliana Shapira; Deborah Collyar; Teresa Deshields; Nancy Lin; Ian Krop; Hans Grunwald; Paula Friedman; Ann H Partridge; Richard L Schilsky; Monica M Bertagnolli
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

8.  Research biopsies in phase I studies: views and perspectives of participants and investigators.

Authors:  Rebecca D Pentz; R Donald Harvey; Margaret White; Zachary Luke Farmer; Olga Dashevskaya; Zhengjia Chen; Colleen Lewis; Taofeek K Owonikoko; Fadlo R Khuri
Journal:  IRB       Date:  2012 Mar-Apr

9.  Patient willingness to undergo pharmacodynamic and pharmacokinetic tests in early phase oncology trials.

Authors:  Raoul Tibes; Barbara F Piper; Jessica A Smith; Raysenia L James; Martin A Benjamin; Jay H Yim; Ramesh K Ramanathan; Daniel D Von Hoff; R Curtis Bay; Mitesh J Borad
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

10.  If you need help, just ask: underestimating compliance with direct requests for help.

Authors:  Francis J Flynn; Vanessa K B Lake
Journal:  J Pers Soc Psychol       Date:  2008-07
View more
  5 in total

1.  "As Long as You Ask": A Qualitative Study of Biobanking Consent-Oncology Patients' and Health Care Professionals' Attitudes, Motivations, and Experiences-the B-PPAE Study.

Authors:  Sonia Yip; Jennifer Fleming; Heather L Shepherd; Adam Walczak; Jonathan Clark; Phyllis Butow
Journal:  Oncologist       Date:  2018-11-09

2.  Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.

Authors:  Sander Bins; Geert A Cirkel; Christa G Gadellaa-Van Hooijdonk; Fleur Weeber; Isaac J Numan; Annette H Bruggink; Paul J van Diest; Stefan M Willems; Wouter B Veldhuis; Michel M van den Heuvel; Rob J de Knegt; Marco J Koudijs; Erik van Werkhoven; Ron H J Mathijssen; Edwin Cuppen; Stefan Sleijfer; Jan H M Schellens; Emile E Voest; Marlies H G Langenberg; Maja J A de Jonge; Neeltje Steeghs; Martijn P Lolkema
Journal:  Oncologist       Date:  2016-09-23

3.  Perceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findings.

Authors:  Davinia S Seah; Nabihah Tayob; Jose Pablo Leone; Jiani Hu; Jun Yin; Melissa Hughes; Sarah M Scott; Ruth I Lederman; Elizabeth Frank; Jessica J Sohl; Zsofia K Stadler; Timothy K Erick; Jeffrey Peppercorn; Eric P Winer; Stuart G Silverman; Steven E Come; Nancy U Lin
Journal:  Breast Cancer Res Treat       Date:  2022-01-23       Impact factor: 4.872

Review 4.  Cultured circulating tumor cells and their derived xenografts for personalized oncology.

Authors:  Ruoxiang Wang; Gina C Y Chu; Stefan Mrdenovic; Alagappan A Annamalai; Andrew E Hendifar; Nicholas N Nissen; James S Tomlinson; Michael Lewis; Nallasivam Palanisamy; Hsian-Rong Tseng; Edwin M Posadas; Michael R Freeman; Stephen J Pandol; Haiyen E Zhau; Leland W K Chung
Journal:  Asian J Urol       Date:  2016-08-25

5.  Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.

Authors:  Leona M Batten; Indrani Subarna Bhattacharya; Laura Moretti; Joanne S Haviland; Marie A Emson; Sarah E Miller; Monica Jefford; Mairead MacKenzie; Maggie Wilcox; Marie Hyslop; Rachel Todd; Claire F Snowdon; Judith M Bliss
Journal:  Res Involv Engagem       Date:  2018-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.